Products & Review
ESBL plus panels
Confirmation and susceptibility testing for ESβL-producing organisms using CLSI recommended dilutions
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
Organisms possessing Extended-Spectrum Beta-Lactamases (ESβL) may be clinically resistant to therapy with penicillins, cephalosporins, and aztreonam, despite apparent in vitro susceptibility to some of these agents. The incidence of these strains is on the rise and is a significant health concern in some regions. Because of this, the screening and confirmation of ESβL-producing strains is recommended by all major national guidelines. Features:
- Fulfills CLSI recommendations for the testing of E. coli, K. pneumoniae, K. oxytoca, and P. mirabilis
- Supports testing of other ESβL producing gram-negative bacteria, outside the United States
- PROMPT™ or turbidity inoculation method provides workflow flexibility
- Manual processing enables ESβL plus panels to be used in any laboratory situation
- Minimum inhibitory concentration (MIC) only panels have room temperature stability for 1-year for convenient storage
- Use ESβL plus panels to study other types of beta-lactamase production in gram-negative bacteria, such as ampC, outside the United States
